According to The Insight Partners, The Veterinary Molecular Diagnostics Market size is expected to reach US$ 2.61 Billion by 2034 from US$ 1.31 Billion in 2025. The market is estimated to record a CAGR of 9.00% from 2026 to 2034. The market’s expansion is supported by increasing pet ownership, rising incidence of animal diseases, growing awareness of animal health, and technological advancements in molecular testing. The Insight Partners identifies PCR, NGS, digital PCR, and microarrays as key technologies, while applications include infectious diseases, genetic testing, oncology, toxicology, and blood typing.
Veterinary Molecular Diagnostics Market Size, Share, Trends, Analysis, and Forecast by 2034
- Market Size: Expected to reach US$ 2.61 Billion by 2034, compared with US$ 1.31 Billion in 2025.
- CAGR: Estimated to grow at 9.00% from 2026 to 2034.
- Key Technologies: PCR, next-generation sequencing, digital PCR, and microarrays.
Download Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00040023
- Major Applications: Infectious diseases, genetic testing, oncology, toxicology, and blood typing.
- Animal Types: Companion animals, livestock, horses, and other animals.
- End Users: Veterinary clinics, animal hospitals, research institutes, and diagnostic laboratories.
- Growth Drivers: Increasing pet ownership, rising animal disease incidence, and advances in molecular diagnostic technologies.
- Emerging Trends: Point-of-care molecular testing, genetic testing, telemedicine integration, and development of breed-specific diagnostic kits.
Market Trends and Growth Drivers
One of the major factors driving the Veterinary Molecular Diagnostics Market is the increasing prevalence of infectious and zoonotic diseases. Molecular testing can support rapid identification of pathogens and help veterinary professionals implement appropriate treatment and disease-control measures. Growing pet ownership is another important factor, as owners increasingly seek preventive and specialized healthcare services for companion animals.
Technological advancements are further transforming veterinary diagnostics. PCR-based testing provides sensitive detection of pathogens, while NGS enables broader genetic analysis. Digital PCR and other advanced technologies can expand testing capabilities for veterinary clinics and laboratories. The increasing availability of point-of-care diagnostics is also creating opportunities to move molecular testing closer to veterinary practices and animal care settings.
Regional Analysis
North America is a significant region in the veterinary diagnostics landscape, supported by developed veterinary healthcare infrastructure, established diagnostic laboratories, high levels of pet ownership, and the presence of major industry participants. The region includes the US, Canada, and Mexico. Europe represents another important market, while Asia-Pacific offers growth opportunities associated with expanding veterinary services, rising pet ownership, increasing disposable income, and improvements in animal healthcare infrastructure. South and Central America and the Middle East and Africa are also covered in the market’s geographical assessment.
Key Players
The Veterinary Molecular Diagnostics Market features companies developing and supplying molecular diagnostic technologies, testing platforms, kits, reagents, and veterinary healthcare solutions. Key players identified by The Insight Partners include:
- IDEXX Laboratories, Inc.
- Zoetis Inc.
- Thermo Fisher Scientific Inc.
- Virbac
- Qiagen N.V.
- Biogal Galed Labs
- Abaxis Inc. (now part of Zoetis)
- Randox Laboratories
- Neogen Corporation
- Randox Laboratories
Organoids Market Size, Share, Trends, Analysis, and Forecast by 2034
- Market Size: Assessment of the global organoids market through 2034.
- Market Share: Analysis of market participation across major regions and application segments.
- Key Trends: Increasing adoption of 3D cell culture, personalized medicine, drug discovery, and disease modeling.
- Market Analysis: Evaluation of technology developments, applications, competitive landscape, and emerging opportunities.
- Forecast: Assessment of expected growth patterns and opportunities through 2034.
Future Outlook
The Veterinary Molecular Diagnostics Market is expected to continue evolving as veterinary professionals increasingly prioritize rapid, precise, and technology-driven disease detection. Expansion of point-of-care testing, advances in genomic technologies, increasing adoption of genetic screening, and greater integration of digital veterinary services are expected to influence future market development. In addition, collaborations between diagnostic companies, veterinary clinics, research institutions, and animal-health organizations could support the development of more specialized testing solutions.
Get Premium Market Research Report Here: https://www.theinsightpartners.com/buy/TIPRE00040023
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
